Literature DB >> 12952958

Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein.

Kuen-Phon Wu1, Chih-Wei Wu, Ya-Ping Tsao, Ting-Wei Kuo, Yuan-Chao Lou, Cheng-Wen Lin, Suh-Chin Wu, Jya-Wei Cheng.   

Abstract

The flavivirus envelope protein is the dominant antigen in eliciting neutralizing antibodies and plays an important role in inducing immunologic responses in the infected host. We have determined the solution structure of the major antigenic domain (domain III) of the Japanese encephalitis virus (JEV) envelope protein. The JEV domain III forms a beta-barrel type structure composed of six antiparallel beta-strands resembling the immunoglobulin constant domain. We have also identified epitopes of the JEV domain III to its neutralizing antibody by chemical shift perturbation measurements. Site-directed mutagenesis experiments are performed to confirm the NMR results. Our study provides a structural basis for understanding the mechanism of immunologic protection and for rational design of vaccines effective against flaviviruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952958     DOI: 10.1074/jbc.M307776200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Backbone and side chain resonance assignments of domain III of the tick-borne Langat flavivirus envelope protein.

Authors:  Munia Mukherjee; Kaushik Dutta; Steven M Pascal; Robert O Fox
Journal:  J Biomol NMR       Date:  2004-08       Impact factor: 2.835

2.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

3.  Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.

Authors:  Tetsuya Harakuni; Hideki Sugawa; Ai Komesu; Masayuki Tadano; Takeshi Arakawa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition.

Authors:  Munia Mukherjee; Kaushik Dutta; Mark A White; David Cowburn; Robert O Fox
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

5.  Solution structure of the envelope protein domain III of dengue-4 virus.

Authors:  David E Volk; Yi-Chien Lee; Xin Li; Varatharasa Thiviyanathan; Gregory D Gromowski; Li Li; Ashley R Lamb; David W C Beasley; Alan D T Barrett; David G Gorenstein
Journal:  Virology       Date:  2007-03-29       Impact factor: 3.616

6.  Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Authors:  Shuliu Zhang; Evgeniy I Bovshik; Rodrigo Maillard; Gregory D Gromowski; David E Volk; Catherine H Schein; Claire Y-H Huang; David G Gorenstein; James C Lee; Alan D T Barrett; David W C Beasley
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

7.  West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.

Authors:  Bärbel Kaufmann; Grant E Nybakken; Paul R Chipman; Wei Zhang; Michael S Diamond; Daved H Fremont; Richard J Kuhn; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

8.  An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus.

Authors:  Ruikun Du; Manli Wang; Zhihong Hu; Hualin Wang; Fei Deng
Journal:  Virol Sin       Date:  2015-09-30       Impact factor: 4.327

9.  Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.

Authors:  Matthew R Vogt; Bastiaan Moesker; Jaap Goudsmit; Mandy Jongeneelen; S Kyle Austin; Theodore Oliphant; Steevenson Nelson; Theodore C Pierson; Jan Wilschut; Mark Throsby; Michael S Diamond
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  Inhibition of Japanese encephalitis virus infection by flavivirus recombinant E protein domain III.

Authors:  Jingjing Fan; Yi Liu; Xuping Xie; Bo Zhang; Zhiming Yuan
Journal:  Virol Sin       Date:  2013-05-25       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.